AI is already playing a fundamental role in every stage of the drug discovery process – from ideation all the way through to drugs reaching patients. This integration is accelerating innovation and ...

Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to industry experts.

The new, sustainable production method could help to address the high costs of crucial drugs like statins, antibiotics and HIV inhibitors.

Founded by a co-creator of ChatGPT, Periodic Labs aims to build artificial intelligence that can accelerate discoveries in physics, chemistry and other fields.

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem ...

We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is to build a comprehensive platform powered by novel technologies that improve ...

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and transforming the way medicines are discovered, tested and delivered.

Ubiquitin controls the lifespan and distribution of proteins in the cell, but it can also determine their shape, function, or interactions with other cellular components. Ubiquitin ligases are key to ...

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing years of research to months.

Antibiotic resistance has become one of the most pressing threats to global health. Infections once treatable with a simple prescription are becoming harder, sometimes impossible, to cure.